PET Tracers · Nucleascope

I.Fiches détaillées multi-public

Catalogue des traceurs TEP avec fiches enrichies pour les médecins nucléaires, radiopharmaciens et physiciens médicaux. Indications cliniques, protocoles d'acquisition, contrôle qualité, dosimétrie ICRP et pièges d'interprétation — mise à jour selon les guidelines EANM, ESMO et SNMMI.

Traceurs disponibles

Cliquez sur un traceur pour ouvrir sa fiche complète ci-dessous.

Indications cliniques principales

Triées par fréquence d'utilisation. Sources : EANM, ESMO, SNMMI.

Protocole d'acquisition

Injection IV

t = 0

Uptake

Acquisition

Fin examen

Préparation patient & pièges

✅ Préparation

⚠️ Pièges & artefacts

Production & contrôle qualité

🏭 Voie de production

📋 Contrôle qualité (PE)

Stabilité & logistique

📦 Conditionnement

🚚 Distribution

Paramètres physiques

⚛️ Radionucléide

📊 Dosimétrie ICRP 128

Optimisation acquisition

🎯 Paramètres TEP-TDM

🛡️ Radioprotection

III.Reference document — PDF version

Synthesis document formatted for printing and clinical archiving. Pharmacokinetics, indications, theranostics and cross-cutting practical notes.

About this document

Synthesis of PET tracers used in European clinical practice — applicable to all EEA/Switzerland Member States: centralised EMA MA, national MAs, regulated hospital preparations and research access.

Download the PDF

References: EANM/SNMMI 2018-2024, SFMN, EMA EPAR, Swissmedic, HAS, AFMPS, BfArM, AIFA, AEMPS & other national authorities of the EEA
Scope: 22 PET tracers · 33 clinical indications · 14 theranostic pairs
PDF format: 14 A4 portrait pages, homogeneous and verified at rendering.
Author: Dr. Erard le Beau de Hemricourt · nucleascope.eu
Disclaimer: Document to be adapted to SmPCs and local procedures in force in each country.

Acronyms and abbreviations

MA: Marketing Authorisation
EMA: European Medicines Agency
EPAR: European Public Assessment Report — EMA public assessment report
EANM: European Association of Nuclear Medicine
SNMMI: Society of Nuclear Medicine and Molecular Imaging (USA)
SFMN: French Society of Nuclear Medicine
HAS: Haute Autorité de Santé (France) — assessment and recommendations
AFMPS: Federal Agency for Medicines and Health Products (Belgium)
Swissmedic: Swiss authority for authorisation and supervision of therapeutic products
BfArM: Bundesinstitut für Arzneimittel und Medizinprodukte (Germany)
AIFA: Agenzia Italiana del Farmaco (Italy)
AEMPS: Agencia Española de Medicamentos y Productos Sanitarios (Spain)
SmPC: Summary of Product Characteristics

Non-exhaustive list — each Member State has its own national competent authority recognised by the EMA.

II.Dynamic view: by tracer or disease

Explore in both directions: start from a disease to see its candidate tracers, or start from a tracer to find all its indications. Satellites are clickable — a click automatically swaps the centre of the constellation. Hover over truncated text to see the full version.

↔

—

Click a tracer satellite

Solid line = first-line Blue dashed = alternative Grey dashed = historical

Marketing authorisations verified: 05/2026 · ema.europa.eu · has-sante.fr · ansm.sante.fr